In 2020, Duke joined the National COVID Cohort Collaborative (N3C), a large collaborative run by the NIH’s National Center for Advancing Translational Science (NCATS) that attempts to make COVID-19 research at institutions like Duke easier.
N3C aims to build a centralized national data resource that the research community can use to study COVID-19 and identify potential treatments. Specifically, the N3C will enable the rapid collection and analysis of clinical, laboratory and diagnostic data from hospitals and health care plans.
Along with NCATS, many other Clinical and Translational Science Awards (CTSA) Program hubs - including Duke - and the National Center for Data to Health (CD2H), will contribute and use COVID-19 clinical data to answer critical research questions to address the pandemic. However, access to this data is not limited to participating groups; anyone who receives approval for a Data Use Request (DUR) can access N3C data to help with their research projects.
To date, at least 7 approved projects have been submitted by Duke investigators.
As part of this collaborative, Duke has an institutional Date Use Agreement in place. Duke investigators can create an account and join an existing team or project, or submit a Data Use Request (https://covid.cd2h.org/dur) for a project if there isn’t an existing team to join.
Visit the N3C website to learn more and to apply for access.